Target intelligence / Profile preview

Actinide, lanthanide, and heavy metal ions

Molecular classification
Metal ions, Radionuclides, Exogenous toxins
01

Overview

Actinides, lanthanides, and heavy metal ions represent a diverse group of exogenous elements that pose significant toxicological risks or serve specialized diagnostic roles. This group includes transuranic elements like Plutonium, Curium, and Californium, which are primarily radiological hazards, as well as heavy metals like Lead, which is a potent neurotoxin (Source: CDC, StatPearls). These ions are not traditional therapeutic targets such as receptors or enzymes; instead, they are the subjects of chelation therapy designed to facilitate their clearance from the body. In the case of lanthanides like Gadolinium, they are utilized as contrast agents in magnetic resonance imaging but require careful management to avoid systemic toxicity such as Nephrogenic Systemic Fibrosis (Source: FDA). The primary mechanism of pharmacological interaction involves the formation of stable coordination complexes with chelating agents like DTPA or EDTA, which enhances renal excretion. Managing these ions is crucial in clinical toxicology, radiology, and public health contexts to prevent organ damage and long-term health complications from environmental or industrial exposure.

Other names
RadionuclidesHeavy metalsTransuranic elementsf-block elementsToxic metal ions
02

Mechanism of action

Chelation therapy: The drugs act as ligands that form stable, water-soluble coordination complexes with the metal ions, preventing their binding to cellular components and facilitating renal or biliary excretion (Source: FDA, StatPearls).

03

Biological functions

None (Exogenous/Toxic)
04

Disease associations

Heavy metal poisoningRadiation sicknessLead poisoningNephrogenic systemic fibrosisAcute radiation syndromeNeurotoxicity
05

Safety considerations

Depletion of essential trace metals (Zinc, Manganese, Magnesium)Nephrotoxicity of chelating agentsRedistribution of metals to the central nervous systemInjection site reactionsTeratogenicity (for certain chelators)
06

Interacting drugs

Pentetate calcium trisodium (Ca-DTPA)

6 more in the full profile.

07

Biomarkers

Blood lead levels (BLL)Urinary radionuclide excretionSerum creatinineWhole-body radiation counting

Beyond the preview

Go deeper on Actinide, lanthanide, and heavy metal ions.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actinide, lanthanide, and heavy metal ions.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call